- Conference
- May 2025
- 4 Days
Global
€1689EUR$1,921USD£1,399GBP
- Conference
- November 2025
- 4 Days
Global
€1448EUR$1,646USD£1,199GBP
€1689EUR$1,921USD£1,399GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2023
- 255 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- October 2023
- 81 Pages
Canada
From €3185EUR$3,500USD£2,731GBP
- Report
- May 2024
- 54 Pages
Global
From €451EUR$495USD£386GBP
- Report
- June 2019
- 144 Pages
Vietnam
€1816EUR$1,995USD£1,557GBP
The Drug Patent market is an important part of the Pharmaceutical industry. It is the process of obtaining a patent for a new drug or medicine, which grants the patent holder exclusive rights to manufacture, market, and sell the drug. This process is highly regulated and requires extensive research and development to ensure the safety and efficacy of the drug. The patent holder is also responsible for ensuring that the drug is properly tested and approved by the relevant regulatory bodies.
The Drug Patent market is highly competitive, with many companies vying for the rights to develop and market new drugs. Companies in the market include Pfizer, Merck, GlaxoSmithKline, Novartis, Sanofi, AstraZeneca, and Johnson & Johnson. Show Less Read more